ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	31481499	A384V	BLLF1	BLLF1	Lymphoma, Large B-Cell, Diffuse		View
2	31481499	G397A	BLLF1	BLLF1	Lymphoma, Large B-Cell, Diffuse		View
3	31481499	G498D	BLLF1	BLLF1	Lymphoma, Large B-Cell, Diffuse		View
4	31481499	P733L	BLLF1	BLLF1	Lymphoma, Large B-Cell, Diffuse		View
5	31481499	R813I	BLLF1	BLLF1	Lymphoma, Large B-Cell, Diffuse		View
6	31481499	A625T	BLLF1	BLLF1	Nasopharyngeal Carcinoma		View
7	31481499	I657R	BLLF1	BLLF1	Nasopharyngeal Carcinoma		View
8	31481499	P512A	BLLF1	BLLF1	Nasopharyngeal Carcinoma		View
9	31481499	P635S	BLLF1	BLLF1	Nasopharyngeal Carcinoma		View
10	31481499	P673S	BLLF1	BLLF1	Nasopharyngeal Carcinoma		View
11	31481499	Q642P	BLLF1	BLLF1	Nasopharyngeal Carcinoma		View
12	31481499	Q754K	BLLF1	BLLF1	Nasopharyngeal Carcinoma		View
13	31481499	S509P	BLLF1	BLLF1	Nasopharyngeal Carcinoma		View
14	31481499	P812T	BLLF1	BLLF1	Nasopharyngeal Carcinoma Burkitt Lymphoma		View
15	31481499	E201Q	BLLF1	BLLF1	Nasopharyngeal Carcinoma Burkitt Lymphoma Lymphoma, Large B-Cell, Diffuse		View
16	31481499	D441A	BLLF1	BLLF1	Nasopharyngeal Carcinoma Lymphoma, Large B-Cell, Diffuse		View
17	31481499	G805D	BLLF1	BLLF1	Nasopharyngeal Carcinoma Lymphoma, Large B-Cell, Diffuse		View
18	31481499	I710T	BLLF1	BLLF1	Nasopharyngeal Carcinoma Lymphoma, Large B-Cell, Diffuse		View
19	31481499	N672I	BLLF1	BLLF1	Nasopharyngeal Carcinoma Lymphoma, Large B-Cell, Diffuse		View
20	31481499	W495R	BLLF1	BLLF1	Nasopharyngeal Carcinoma Lymphoma, Large B-Cell, Diffuse		View
21	29093097	E201Q	BLLF1	BLLF1	Stomach Neoplasms	R S	View
22	29093097	W495R	BLLF1	BLLF1	Stomach Neoplasms	R S	View
23	29093097	N672I	BLLF1	BLLF1	Stomach Neoplasms	R S	View

Contents
Description

The table shows all curated mutation sites of EBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.